Seeking Alpha
View as an RSS Feed

Peter Epstein  

View Peter Epstein's Comments BY TICKER:
Latest  |  Highest rated
  • Energy Fuels Inc: An Under-Appreciated Nuclear Renaissance Story [View article]
    Energy Fuels is still trading at a whopping 69% discount to the average of URZ, URG, PDN and UEC. That's on an EV/LBS ratio basis.

    Even though Energy Fuels stock has ripped higher, URZ and URG stocks have done the same or better and are up over 100% from their respective 52-week lows. So, the while the uranium tide is lifting all boats, there's still A LOT of room for Energy Fuels to close the valuation gap.
    Feb 26, 2014. 02:42 PM | 1 Like Like |Link to Comment
  • Interview With Uranium Expert Mickey Fulp, He Loves Energy Fuels Inc. [View article]
    EFR still trading at a large discount to the average of Uranerz, Paladin, UR-Energy and UEC on an EV/LBS ratio basis...
    Feb 26, 2014. 10:24 AM | 1 Like Like |Link to Comment
  • Energy Fuels Inc: An Under-Appreciated Nuclear Renaissance Story [View article]
    EFR still trading at a large discount to the average of Uranerz, Paladin, UR-Energy and UEC on an EV/LBS ratio basis.
    Feb 26, 2014. 10:23 AM | 1 Like Like |Link to Comment
  • Energy Fuels: Deep Value In Uranium [View article]
    I wish I bought more....but I already own several other natural resource stocks, not just Energy Fuels.

    EFR still trading at a large discount to the average of Uranerz, Paladin, UR-Energy and UEC on an EV/LBS ratio basis.
    Feb 26, 2014. 10:22 AM | 1 Like Like |Link to Comment
  • Interview With Uranium Expert Mickey Fulp, He Loves Energy Fuels Inc. [View article]
    UUUU was oversold due to unhappiness over the reverse split. It's had a nice run, but is not up more than peers.

    A lot of uranium stocks have moved significantly higher. The latest excitement comes from several articles and comments suggesting that Japan is finally moving towards reactor restarts. The upside is that as many as 10 reactors will be back online by the end of the summer.

    Just like some of the uranium stocks that have gapped up well over 100% from 52-week lows, the uranium spot price might see a gap higher, or at least greater than just a few dollars/lb. When utility demand picks up, uranium sellers will have the opportunity (if they are wise) to hold out for more than just the upper $30's/lb.

    Will we see a $45/lb spot price by the end of the summer?
    Feb 25, 2014. 05:26 PM | 1 Like Like |Link to Comment
  • Interview With Uranium Expert Mickey Fulp, He Loves Energy Fuels Inc. [View article]
    UUUU up 75% since Mickey Fulp report on December 27th!
    Feb 25, 2014. 04:02 PM | 1 Like Like |Link to Comment
  • Energy Fuels: Deep Value In Uranium [View article]
    Great timing on your article!

    UUUU is up 80% since December 18th.
    Feb 25, 2014. 03:59 PM | Likes Like |Link to Comment
  • New Mandate Will Help Sell Veriteq's FDA-Approved Microchip [View article]
    VeriTeQ Corporation commented [February 24, 2014] on the latest breast implant recall in the European Union. Breast implants manufactured by French company Cereplas are being recalled by The National Security Agency of Medicines and Health Products (“ANSM”) due to concerns regarding sterilization and equipment used in production of the implants.

    The ANSM in the EU has suspended the marketing, distribution and use of breast implants and sizers from Cereplas until the company achieves compliance with regulations, which include control of the process of sterilization and qualification of equipment used in production. Cereplas’ CE marking Certificates for its breast implants have also been suspended.

    “This new recall of breast implants is the latest example of regulators pushing for higher standards for medical devices following the PIP scare in the EU,” said Scott R. Silverman, Chairman and CEO of VeriTeQ. “Furthermore, it serves as another reminder for manufacturers, physicians and patients of the need for advanced device traceability technologies like VeriTeQ’s Q Inside Safety Technology, that can externally retrieve the device information without the stress and risk of a re-operation.”

    VeriTeQ’s Q Inside Safety Technology acts as an electronic serial number in breast implants and other implantable and reusable medical devices to identify them during a recall or adverse event to help ensure patient safety.

    VeriTeQ is currently working with breast implant manufacturer Establishment Labs, S.A. (“EL”), which markets its Motiva Implant Matrix® breast implants with VeriTeQ’s Q Inside Safety Technology in the EU. EL’s CE cleared Motiva Implant Matrix® product line with VeriTeQ’s Q Inside Safety Technology offers the world’s first externally identifiable breast implant.

    By including VeriTeQ’s FDA cleared Q Inside Safety Technology in breast implants and other medical devices, manufacturers, physicians and patients will have access to a secure online database to retrieve device-specific data such as serial number, manufacturer name, date of manufacture, lot number, volume, size, and other data from the medical device manufacturer. Q Inside Safety Technology also provides an extra level of protection to the patient in the event of a recall or other safety event as it provides accurate and immediate confirmation of the origin of a patient’s medical device.

    About EL

    Establishment Labs is a privately held, global breast, body and facial aesthetic company with offices in Florida, Costa Rica and Belgium, that designs, develops, manufactures and markets an innovative product portfolio consisting of advanced silicone-filled breast (http://bit.ly/1mD1hLk) and body shaping implants. Utilizing only the highest quality of medical grade silicones, the CE-marked Motiva Implant Matrix® line is rigorously scrutinized by professional Quality Engineers throughout the entire manufacturing process. All its products are produced in full compliance with ISO and EU requirements, and are certified under the Medical Device Directive 93/42/EEC. For more information on EL, please visit http://bit.ly/1mD1i1z.

    About VeriTeQ

    VeriTeQ develops innovative, proprietary RFID technologies for implantable medical device identification, and dosimeter technologies for use in radiation therapy treatment. VeriTeQ offers the world's first FDA cleared RFID microchip technology that can be used to identify implantable medical devices, in vivo, on demand, at the point of care. VeriTeQ's dosimeters provide patient safety mechanisms while measuring and recording the dose of radiation delivered to a patient in real time.
    Feb 24, 2014. 10:33 AM | Likes Like |Link to Comment
  • Scrutiny Over Medical Device Safety Offers Opportunity For VeriTeQ [View article]
    VeriTeQ Corporation commented [February 24, 2014] on the latest breast implant recall in the European Union. Breast implants manufactured by French company Cereplas are being recalled by The National Security Agency of Medicines and Health Products (“ANSM”) due to concerns regarding sterilization and equipment used in production of the implants.

    The ANSM in the EU has suspended the marketing, distribution and use of breast implants and sizers from Cereplas until the company achieves compliance with regulations, which include control of the process of sterilization and qualification of equipment used in production. Cereplas’ CE marking Certificates for its breast implants have also been suspended.

    “This new recall of breast implants is the latest example of regulators pushing for higher standards for medical devices following the PIP scare in the EU,” said Scott R. Silverman, Chairman and CEO of VeriTeQ. “Furthermore, it serves as another reminder for manufacturers, physicians and patients of the need for advanced device traceability technologies like VeriTeQ’s Q Inside Safety Technology, that can externally retrieve the device information without the stress and risk of a re-operation.”

    VeriTeQ’s Q Inside Safety Technology acts as an electronic serial number in breast implants and other implantable and reusable medical devices to identify them during a recall or adverse event to help ensure patient safety.

    VeriTeQ is currently working with breast implant manufacturer Establishment Labs, S.A. (“EL”), which markets its Motiva Implant Matrix® breast implants with VeriTeQ’s Q Inside Safety Technology in the EU. EL’s CE cleared Motiva Implant Matrix® product line with VeriTeQ’s Q Inside Safety Technology offers the world’s first externally identifiable breast implant.

    By including VeriTeQ’s FDA cleared Q Inside Safety Technology in breast implants and other medical devices, manufacturers, physicians and patients will have access to a secure online database to retrieve device-specific data such as serial number, manufacturer name, date of manufacture, lot number, volume, size, and other data from the medical device manufacturer. Q Inside Safety Technology also provides an extra level of protection to the patient in the event of a recall or other safety event as it provides accurate and immediate confirmation of the origin of a patient’s medical device.

    About EL

    Establishment Labs is a privately held, global breast, body and facial aesthetic company with offices in Florida, Costa Rica and Belgium, that designs, develops, manufactures and markets an innovative product portfolio consisting of advanced silicone-filled breast (http://bit.ly/1mD1hLk) and body shaping implants. Utilizing only the highest quality of medical grade silicones, the CE-marked Motiva Implant Matrix® line is rigorously scrutinized by professional Quality Engineers throughout the entire manufacturing process. All its products are produced in full compliance with ISO and EU requirements, and are certified under the Medical Device Directive 93/42/EEC. For more information on EL, please visit http://bit.ly/1mD1i1z.

    About VeriTeQ

    VeriTeQ develops innovative, proprietary RFID technologies for implantable medical device identification, and dosimeter technologies for use in radiation therapy treatment. VeriTeQ offers the world's first FDA cleared RFID microchip technology that can be used to identify implantable medical devices, in vivo, on demand, at the point of care. VeriTeQ's dosimeters provide patient safety mechanisms while measuring and recording the dose of radiation delivered to a patient in real time. For more information on VeriTeQ, please visit http://bit.ly/1mD1i1C.
    Feb 24, 2014. 10:31 AM | Likes Like |Link to Comment
  • Pershing Gold: Strong Drill Results, Insider Buying And New Research Coverage [View article]
    Gold at $1,319/oz at 7am EST...shorts have to be feeling some pain by now.
    Feb 14, 2014. 07:03 AM | 1 Like Like |Link to Comment
  • The Golden Touch Of Pershing Gold's Major Shareholder [View article]
    hopefully tomorrow the stock stays above 40 cents on strong trading volume. we will see.
    Feb 13, 2014. 04:54 PM | 1 Like Like |Link to Comment
  • Pershing Gold: Strong Drill Results, Insider Buying And New Research Coverage [View article]
    Strongest day for PGLC in a long, long time. Gold price above $1,300/oz didn't hurt either.

    Feb 13, 2014. 04:37 PM | 2 Likes Like |Link to Comment
  • Energy Fuels Inc: An Under-Appreciated Nuclear Renaissance Story [View article]
    Energy Fuels stock performing well of late. Hopefully accumulation by institutions a factor...
    Feb 13, 2014. 03:19 PM | 1 Like Like |Link to Comment
  • Fission Uranium - Still Undervalued With 50%-125% Upside [View article]
    I agree that Fission is pretty good. But, why not buy NexGen Energy [NXE] for 1/10th the market cap valuation of Fission? NexGen appears to be 2 years behind Fission, with a very similar resource.
    Feb 13, 2014. 02:24 PM | 1 Like Like |Link to Comment
  • Pershing Gold: Strong Drill Results, Insider Buying And New Research Coverage [View article]
    Actually LisaE,

    PGLC stock now up 8% and approaching 2 million shares traded.
    Feb 13, 2014. 02:09 PM | 2 Likes Like |Link to Comment
COMMENTS STATS
1,763 Comments
1,570 Likes